» Articles » PMID: 12430901

Monitoring the Course of Chronic Myelogenous Leukemia by Fluorescence in Situ Hybridization

Overview
Journal Int J Hematol
Specialty Hematology
Date 2002 Nov 15
PMID 12430901
Authors
Affiliations
Soon will be listed here.
References
1.
Seong D, Thall P, Kantarjian H, Talpaz M, Swantkowski J, Xu J . Philadelphia chromosome-positive myeloid cells in the peripheral blood of chronic myelogenous leukemia patients: comparison with the frequency detected in cycling cells of the bone marrow. Clin Cancer Res. 1998; 4(4):861-7. View

2.
Kolb H, Schattenberg A, Goldman J, Hertenstein B, Jacobsen N, Arcese W . Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood. 1995; 86(5):2041-50. View

3.
Joos S, Fink T, Ratsch A, Lichter P . Mapping and chromosome analysis: the potential of fluorescence in situ hybridization. J Biotechnol. 1994; 35(2-3):135-53. DOI: 10.1016/0168-1656(94)90032-9. View

4.
Tkachuk D, Westbrook C, Andreeff M, Donlon T, Cleary M, Suryanarayan K . Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization. Science. 1990; 250(4980):559-62. DOI: 10.1126/science.2237408. View

5.
Seong D, Giralt S, Fischer H, Hayes K, Glassman A, Arlinghaus R . Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia. Bone Marrow Transplant. 1997; 19(6):565-70. DOI: 10.1038/sj.bmt.1700700. View